Written by Daniel Mollenkamp || 28th March 2019 || Regulatory briefing || FDA | Policy and Politics | Regulation and Legislation | Geographies: North America United States The US FDA has issued a proposed rule to establish requirements for the content and format of substantial equivalence (SE) reports for tobacco products ... Are you already a subscriber? login here Login Username or Email Password Remember me Forget? | Register Username or Email Back to Login | Register Enjoy free subscription accessGet access to premium content that is normally only available for subscribers. For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors. I want a free trial Benefits of subscription plans:Stay informed of any legal and market change in the sector that impacts your organizationMaximise resources by getting market and legal data analysis daily in one placeMake smart decisions by understanding how the regulatory and market landscape evolvesAnticipate risks in your decisions by monitoring regulatory changes that impact your organizationNeed help?Contact a sales representative right now and don’t waitErik Galavis +34 654 320 547 Email Erik Related contents Exit Gottlieb, the ‘friend of vaping’ who became its outspoken foe PMTA and MRTP: navigating the path to FDA approval for reduced-risk products Substantial equivalence: Eclipse and Glo – same difference?